Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA)

A Resource for Healthcare and Social Services Professionals


Back to calendar

Back to event list

Event summary

Buprenorphine Waiver Training - OB/GYN Focus - PART 1

This event is intended to provide four hours of required training for providers seeking their buprenorphine waivers. This FREE course educates physicians, nurse practitioners, and physician assistants on prescribing buprenorphine for the treatment of opioid use disorder, with particular attention to the treatment of women during pregnancy and postpartum.

Event details


This course comprises the first half of the eight-hour buprenorphine waiver course.

ALL REGISTRANTS MUST COMPLETE THE SECOND FOUR HOURS ONLINE AFTER THIS EVENT. After the event, you will be sent a link to complete the second part of the eight-hour waiver training. You must complete the last four hours within 30 days of this training event and pass the online test, or you will be required to retake the full eight hours of training.

The full eight-hour course prepares physicians, nurse practitioners, and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office, with a focus on the treatment of pregnant and postpartum women. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. In addition to addressing the management of buprenorphine treatment in the general population, particular attention will be devoted to the special considerations involved in treating opioid use disorder during pregnancy. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.

Check-in for the course will be from 7:30am-8:00am, and the course will run from 8:00am-12:00pm.

This is an in-person training. There will not be an option to attend via webinar.


Upon completion of the first 4 hours of training in-person and the second 4 hours of training online, the participants will be able to:

Intended audience

Physicians (MD, DO), Nurse Practitioners, and Physician Assistants

Sponsored by

Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training.

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA.  The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government

Accreditation information

Method of physician participation in the learning process: Credit will only be awarded for completing all of the training. To be awarded a Buprenorphine Training Completion Certificate you must complete all 8 hours of the course. Those who finish the full course will be able to complete the waiver application online once their residency is complete.